Pharmaceutical Filtration Market by Product (Membrane, Depth filter), System (Single use, Reusable), Technique (Microfiltration, Nanofiltration), Application (API, Vaccine, Antibody), Scale of Operation (Manufacturing, Pilot, R&D) & Region - Global Forecasts to 2028

Abstract
The pharmaceutical filtration market is expected to grow at a CAGR of 14.2% during the forecast period. The market is estimated to be around USD 13.5 billion in 2023 and is projected to reach USD 26.2 billion by 2028. Growth in the pharmaceutical filtration market can be attributed to factors such as emerging countries like China, India, Brazil, and Mexico offering significant growth opportunities, advancement in nanofiber technology, and increased manufacturing and R&D in the pharmaceutical & biotechnology industries. On the other hand, membrane fouling and the growing capital investment required to set up new production facilities are expected to hinder market growth.

“In 2022 the systems segment accounted for the second largest share of the pharmaceutical market”

Based on products, the pharmaceutical filtration market is segmented into major three segments, namely, filters, systems, and other products. The filter market is further segmented into membrane filters, depth filters, and other filters, such as prefilters, bag filters, and magnetic filters. The systems market is further segmented into single-use systems and reusable systems. In 2022 the systems segment accounted for the second largest share of the pharmaceutical market. The large share of this segment can primarily be attributed rising importance of separation and purification applications. Developments in research techniques and increased demand for more specificity in the filtration process are increasing the adoption of single-use technologies in many small-scale biopharmaceutical processes.

“The ultrafiltration techniques accounted for the second largest market share of this market in 2022”

Based on technique, the pharmaceutical filtration market is segmented into microfiltration, ultrafiltration, nanofiltration, and other techniques. The other techniques segment includes reverse osmosis and ion exchange. The microfiltration techniques accounted for the second largest market share of this market in 2022, and this can be primarily attributed to the implementation of ultrafiltration for cell harvesting and enzyme purification plasma separation. It is also used in the filtration of active pharmaceutical ingredients, media & buffers, formulations, and filling solutions. To a certain extent, UF allows the removal of viruses, phage, colloids, and macromolecules, which cannot be achieved with microfiltration and hence is acquiring large share in the market.

“The sterile filtration technique accounted for the largest market share of this market in 2022”

Based on type, the pharmaceutical filtration market is segmented into sterile filtration and non-sterile filtration. The sterile filtration technique accounted for the largest market share of this market in 2022, and this can be attributed the factors such as the fast growth of biologics, the rapid increase in the requirement of sterile filtration during the liquid processing of biopharmaceuticals, and the benefits of sterile filtration over non-sterile filtration.

Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Parker-Hannifin Corporation (US), Thermo Fisher Scientific Inc. (US), 3M Company (US), Eaton Corporation plc (US), Donaldson Company, Inc. (US), Repligen Corporation (US), Porvair plc (UK), Alfa Laval Corporate AB (Sweden), Corning Incorporated (US), Meissner Filtration Products, Inc. (US), Amazon Filters Ltd. (UK), Graver Technologies, LLC (US), MMS AG (Switzerland), MANN+HUMMEL International GmbH & Co. KG (Germany), ErtelAlsop (US), Kasag Swiss AG (Switzerland), Freudenberg Filtration Technologies SE & Co. KG (Germany), Cole-Parmer Instrument Company, LLC. (US), Cantel Medical Corp. (US), Filtrox AG (Switzerland), Saint-Gobain Performance Plastics (France), and Membrane Solutions (US) are some of the major players operating in the pharmaceutical filtration market.

“Asia Pacific: The fastest-growing region in the pharmaceutical filtration market”

The pharmaceutical filtration market is segmented into North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA). The Asia Pacific is estimated to be the fastest-growing segment of the market owing to the growing incidence rate of viral diseases, the requirement to maintain a clean manufacturing environment because of strict foreign regulatory rules, the fast expansion of generics manufacturing, developments in nanofiber technologies, increasing R&D spending on biopharmaceutical projects, and the growth of the biotechnology industry in developing countries.

The primary interviews conducted for this report can be categorized as follows:
•By Respondent: Supply Side- 80% and Demand Side - 20%
•By Designation: Managers- 45%, CXOs and Director level - 30%, and Executives - 25%
•By Region: North America -20%, Europe -10%, Asia-Pacific -55%, RoW -15%

List of Companies Profiled in the Report:
•Merck KGaA (Germany)
•Danaher Corporation (US)
•Sartorius AG (Germany)
•Parker-Hannifin Corporation (US)
•Thermo Fisher Scientific Inc. (US)
•3M Company (US)
•Eaton Corporation plc (US)
•Donaldson Company, Inc. (US)
•Repligen Corporation (US)
•Porvair plc (UK)
•Alfa Laval Corporate AB (Sweden)
•Corning Incorporated (US)
•Meissner Filtration Products, Inc. (US)
•Amazon Filters Ltd. (UK)
•Graver Technologies, LLC (US)
•MMS AG (Switzerland)
•MANN+HUMMEL International GmbH & Co. KG (Germany)
•ErtelAlsop (US)
•Kasag Swiss AG (Switzerland)
•Freudenberg Filtration Technologies SE & Co. KG (Germany)
•Cole-Parmer Instrument Company, LLC. (US)
•Cantel Medical Corp. (US)
•Filtrox AG (Switzerland)
•Saint-Gobain Performance Plastics (France)
•Membrane Solutions (US)

Research Coverage:
This report provides a detailed picture of the pharmaceutical filtration market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical filtration market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, trends, and opportunities.

Content
Table of Contents

1INTRODUCTION58
1.1STUDY OBJECTIVES58
1.2MARKET DEFINITION58
1.2.1INCLUSIONS AND EXCLUSIONS59
1.3MARKET SCOPE60
1.3.1MARKETS COVERED60
1.3.2YEARS CONSIDERED61
1.4CURRENCY CONSIDERED61
1.5LIMITATIONS61
1.6STAKEHOLDERS62
1.7SUMMARY OF CHANGES62
1.7.1RECESSION IMPACT63
2RESEARCH METHODOLOGY64
2.1RESEARCH DATA64
FIGURE 1RESEARCH DESIGN64
2.1.1SECONDARY DATA65
2.1.2PRIMARY DATA66
FIGURE 2BREAKDOWN OF PRIMARIES, BY RESPONDENT, DESIGNATION, AND REGION66
2.2MARKET ESTIMATION METHODOLOGY67
FIGURE 3PHARMACEUTICAL FILTRATION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 202267
FIGURE 4MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 202268
2.2.1INSIGHTS FROM PRIMARY EXPERTS69
FIGURE 5MARKET SIZE VALIDATION FROM PRIMARY SOURCES69
2.3MARKET GROWTH RATE PROJECTIONS70
FIGURE 6PHARMACEUTICAL FILTRATION MARKET (SUPPLY SIDE): CAGR PROJECTIONS71
FIGURE 7PHARMACEUTICAL FILTRATION MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS72
2.3.1DATA TRIANGULATION73
FIGURE 8DATA TRIANGULATION METHODOLOGY73
2.4RESEARCH ASSUMPTIONS74
2.5IMPACT OF RECESSION74
TABLE 1GLOBAL INFLATION RATE PROJECTION, 2024−2027 (% GROWTH)74
2.6RISK ANALYSIS75
 
3EXECUTIVE SUMMARY76
FIGURE 9PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)76
FIGURE 10PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)77
FIGURE 11PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)77
FIGURE 12PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)78
FIGURE 13PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023 VS. 2028 (USD MILLION)79
FIGURE 14GEOGRAPHICAL SNAPSHOT OF PHARMACEUTICAL FILTRATION MARKET80
4PREMIUM INSIGHTS81
4.1PHARMACEUTICAL FILTRATION MARKET OVERVIEW81
FIGURE 15INCREASING R&D SPENDING IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES TO DRIVE MARKET GROWTH81
4.2NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT AND COUNTRY (2022)82
FIGURE 16FILTERS SEGMENT TO POSSESS LARGEST SHARE OF NORTH AMERICAN PHARMACEUTICAL FILTRATION MARKET IN 202282
4.3PHARMACEUTICAL FILTRATION MARKET SHARE, BY APPLICATION (2023 VS. 2028)82
FIGURE 17FINAL PRODUCT PROCESSING APPLICATIONS SEGMENT TO DOMINATE MARKET IN 202882
4.4PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2022 (USD MILLION)83
FIGURE 18MICROFILTRATION SEGMENT TO DOMINATE MARKET, BY TECHNIQUE, IN 202283
4.5PHARMACEUTICAL FILTRATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES84
FIGURE 19ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE FROM 2023 TO 202884
5MARKET OVERVIEW85
5.1INTRODUCTION85
5.2MARKET DYNAMICS85
FIGURE 20PHARMACEUTICAL FILTRATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES85
TABLE 2PHARMACEUTICAL FILTRATION MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES86
5.2.1DRIVERS87
5.2.1.1Growing biopharmaceutical industry87
TABLE 3INDICATIVE LIST OF BIOLOGICAL LICENSE APPLICATION APPROVALS, 2021 AND 202287
5.2.1.2Rising R&D spending in pharmaceutical and biotechnology industries88
FIGURE 21GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–202888
5.2.1.3Increasing adoption of single-use technologies88
5.2.1.4New product launches by leading market players89
5.2.1.5Increasing purity requirements in end-user segments90
5.2.2RESTRAINTS90
5.2.2.1Membrane fouling issues90
5.2.2.2Requirement of high capital investments for new production facilities90
5.2.3OPPORTUNITIES91
5.2.3.1Growth opportunities in emerging economies91
5.2.3.2Advances in nanofiber technology91
5.2.4CHALLENGES92
5.2.4.1Increased cost and reduced speed and yield of filters92
5.2.4.2Survival of small players and new entrants92
5.3RANGES/SCENARIOS93
FIGURE 22SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF PHARMACEUTICAL FILTRATION MARKET93
5.4TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES94
FIGURE 23REVENUE SHIFT AND NEW REVENUE POCKETS FOR PHARMACEUTICAL FILTRATION PRODUCT PROVIDERS94
5.5PRICING ANALYSIS94
5.5.1AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS94
TABLE 4PRICE OF PHARMACEUTICAL FILTRATION PRODUCTS (2022)94
5.5.2AVERAGE SELLING PRICE TREND94
5.6VALUE CHAIN ANALYSIS95
FIGURE 24VALUE CHAIN ANALYSIS OF PHARMACEUTICAL FILTRATION MARKET96
5.7SUPPLY CHAIN ANALYSIS96
FIGURE 25PHARMACEUTICAL FILTRATION MARKET: SUPPLY CHAIN ANALYSIS97
5.8ECOSYSTEM ANALYSIS98
FIGURE 26ECOSYSTEM ANALYSIS: PHARMACEUTICAL FILTRATION MARKET98
TABLE 5SUPPLY CHAIN ECOSYSTEM99
5.9PATENT ANALYSIS101
FIGURE 27PATENT APPLICATIONS FOR PHARMACEUTICAL FILTRATION MARKET, JANUARY 2012–DECEMBER 2022101
5.10CASE STUDY ANALYSIS101
5.10.1IMPROVED CAPACITY AND EFFICIENCY OF CARBON REMOVAL PROCESS FROM ACTIVE PHARMACEUTICAL INGREDIENTS101
5.10.2FILTER HOUSING CAPABLE OF HANDLING BOTH GAS AND LIQUID102
5.10.33M OFFERS EMPHAZE AEX HYBRID PURIFIER TO REDUCE IMPURITIES IN BIOPHARMACEUTICAL DOWNSTREAM PROCESS102
5.10.4DELIVERY OF POLYPROPYLENE PLEATED CARTRIDGES FOR HIGH-PURITY PHARMACEUTICAL PRODUCTS102
5.10.5USE OF POLYPROPYLENE HIGH-FLOW CARTRIDGE FOR FINAL FILTRATION PROCESS102
5.11KEY CONFERENCES AND EVENTS IN 2023103
TABLE 6PHARMACEUTICAL FILTRATION MARKET: LIST OF CONFERENCES AND EVENTS103
5.12REGULATORY ANALYSIS104
5.12.1LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS IN DIFFERENT REGIONS/COUNTRIES104
5.12.2REGULATORY SCENARIO IN DIFFERENT REGIONS/COUNTRIES105
5.13PORTER’S FIVE FORCES ANALYSIS106
TABLE 7PHARMACEUTICAL FILTRATION MARKET: PORTER’S FIVE FORCES ANALYSIS106
5.13.1THREAT OF NEW ENTRANTS106
5.13.2THREAT OF SUBSTITUTES107
5.13.3BARGAINING POWER OF BUYERS107
5.13.4BARGAINING POWER OF SUPPLIERS107
5.13.5INTENSITY OF COMPETITIVE RIVALRY107
5.14KEY STAKEHOLDERS AND BUYING CRITERIA108
5.14.1KEY STAKEHOLDERS IN PHARMACEUTICAL COMPANIES AND THEIR INFLUENCE ON BUYING PROCESS108
FIGURE 28INFLUENCE OF STAKEHOLDERS IN PHARMACEUTICAL COMPANIES ON BUYING PROCESS OF PHARMACEUTICAL FILTRATION PRODUCTS108
5.14.2KEY BUYING CRITERIA FOR PHARMACEUTICAL FILTRATION PRODUCTS AMONG END USERS108
FIGURE 29KEY BUYING CRITERIA FOR END USERS108
6PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT109
6.1INTRODUCTION110
TABLE 8GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)110
6.2FILTERS110
TABLE 9GLOBAL PHARMACEUTICAL FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION)111
TABLE 10NORTH AMERICA: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)111
TABLE 11EUROPE: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)112
TABLE 12ASIA PACIFIC: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)112
TABLE 13LATIN AMERICA: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)113
TABLE 14GLOBAL PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)113
6.2.1MEMBRANE FILTERS113
TABLE 15GLOBAL PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION)114
TABLE 16NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)114
TABLE 17EUROPE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)115
TABLE 18ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)115
TABLE 19LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)116
TABLE 20PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION)116
6.2.1.1Polyethersulfone (PES)116
TABLE 21GLOBAL PES MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION)117
TABLE 22NORTH AMERICA: PES MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)117
TABLE 23EUROPE: PES MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)118
TABLE 24ASIA PACIFIC: PES MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)118
TABLE 25LATIN AMERICA: PES MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)119
6.2.1.2Polyvinylidene difluoride (PVDF)119
6.2.1.2.1FDA, USP, and EEC compliance to increase demand for PVDF filters119
TABLE 26GLOBAL PVDF MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION)119
TABLE 27NORTH AMERICA: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)120
TABLE 28EUROPE: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)120
TABLE 29ASIA PACIFIC: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)121
TABLE 30LATIN AMERICA: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)121
6.2.1.3Nylon121
6.2.1.3.1Increased endotoxin adsorption capacity of nylon filters to drive growth121
TABLE 31GLOBAL NYLON MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION)122
TABLE 32NORTH AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)122
TABLE 33EUROPE: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)122
TABLE 34ASIA PACIFIC: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)123
TABLE 35LATIN AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)123
6.2.1.4Polytetrafluoroethylene (PTFE)123
6.2.1.4.1PTFE membrane filters offer retention of ratings as fine as 0.01μ123
TABLE 36GLOBAL PTFE MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION)124
TABLE 37NORTH AMERICA: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)124
TABLE 38EUROPE: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)124
TABLE 39ASIA PACIFIC: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)125
TABLE 40LATIN AMERICA: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)125
6.2.1.5Mixed cellulose ester & cellulose acetate (MCE & CA)125
6.2.1.5.1MCE membranes widely used in analytical and research applications125
TABLE 41GLOBAL MCE & CA MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION)126
TABLE 42NORTH AMERICA: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)126
TABLE 43EUROPE: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)127
TABLE 44ASIA PACIFIC: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)127
TABLE 45LATIN AMERICA: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)128
6.2.1.6Polycarbonate track-etched (PCTE)128
6.2.1.6.1PCTE membrane filters widely used in cell biology and analytical testing applications128
TABLE 46GLOBAL PCTE MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION)128
TABLE 47NORTH AMERICA: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)129
TABLE 48EUROPE: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)129
TABLE 49ASIA PACIFIC: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)130
TABLE 50LATIN AMERICA: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)130
6.2.1.7Other materials130
TABLE 51GLOBAL OTHER MATERIAL MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION)131
TABLE 52NORTH AMERICA: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)131
TABLE 53EUROPE: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)132
TABLE 54ASIA PACIFIC: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)132
TABLE 55LATIN AMERICA: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)133
6.2.2DEPTH FILTERS133
TABLE 56GLOBAL DEPTH FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION)134
TABLE 57NORTH AMERICA: DEPTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)134
TABLE 58EUROPE: DEPTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)134
TABLE 59ASIA PACIFIC: DEPTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)135
TABLE 60LATIN AMERICA: DEPTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)135
TABLE 61DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION)135
6.2.2.1Diatomaceous earth136
6.2.2.1.1DE filters used in biotechnology industry for cell clarification136
TABLE 62GLOBAL DIATOMACEOUS EARTH FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION)136
TABLE 63NORTH AMERICA: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)136
TABLE 64EUROPE: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)137
TABLE 65ASIA PACIFIC: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)137
TABLE 66LATIN AMERICA: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)138
6.2.2.2Cellulose138
6.2.2.2.1Cost-effectiveness of cellulose-based depth filters to drive growth138
TABLE 67GLOBAL CELLULOSE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION)138
TABLE 68NORTH AMERICA: CELLULOSE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)139
TABLE 69EUROPE: CELLULOSE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)139
TABLE 70ASIA PACIFIC: CELLULOSE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)140
TABLE 71LATIN AMERICA: CELLULOSE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)140
6.2.2.3Activated carbon140
6.2.2.3.1Reliable and economic activated carbon filters to be used in traditional pharmaceutical manufacturing operations140
TABLE 72GLOBAL ACTIVATED CARBON FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION)141
TABLE 73NORTH AMERICA: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)141
TABLE 74EUROPE: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)142
TABLE 75ASIA PACIFIC: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)142
TABLE 76LATIN AMERICA: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)143
6.2.2.4Perlite143
6.2.2.4.1Lower density of perlite provides more purity than diatomaceous earth143
TABLE 77GLOBAL PERLITE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION)143
TABLE 78NORTH AMERICA: PERLITE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)144
TABLE 79EUROPE: PERLITE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)144
TABLE 80ASIA PACIFIC: PERLITE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)144
TABLE 81LATIN AMERICA: PERLITE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)145
6.2.2.5Other depth filter media145
TABLE 82GLOBAL OTHER DEPTH FILTER MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)145
TABLE 83NORTH AMERICA: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)146
TABLE 84EUROPE: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)146
TABLE 85ASIA PACIFIC: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)147
TABLE 86LATIN AMERICA: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)147
6.2.3OTHER FILTERS147
TABLE 87GLOBAL OTHER PHARMACEUTICAL FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION)148
TABLE 88NORTH AMERICA: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)148
TABLE 89EUROPE: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)149
TABLE 90ASIA PACIFIC: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)149
TABLE 91LATIN AMERICA: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)150
6.3SYSTEMS150
TABLE 92GLOBAL FILTRATION SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)150
TABLE 93NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)151
TABLE 94EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)151
TABLE 95ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)152
TABLE 96LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)152
TABLE 97GLOBAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)152
6.3.1SINGLE-USE SYSTEMS153
6.3.1.1Reduced need for product validation and minimized cross-contamination risk to boost adoption153
TABLE 98GLOBAL SINGLE-USE FILTRATION SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)153
TABLE 99NORTH AMERICA: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)153
TABLE 100EUROPE: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)154
TABLE 101ASIA PACIFIC: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)154
TABLE 102LATIN AMERICA: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)155
6.3.2REUSABLE SYSTEMS155
6.3.2.1Reusable systems widely used for large-scale manufacturing155
TABLE 103GLOBAL REUSABLE SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)155
TABLE 104NORTH AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)156
TABLE 105EUROPE: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)156
TABLE 106ASIA PACIFIC: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)157
TABLE 107LATIN AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)157
6.4OTHER FILTRATION PRODUCTS157
TABLE 108OTHER FILTRATION PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)158
TABLE 109NORTH AMERICA: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)158
TABLE 110EUROPE: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)159
TABLE 111ASIA PACIFIC: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)159
TABLE 112LATIN AMERICA: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)160
TABLE 113OTHER FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)160
6.4.1FILTRATION ASSEMBLIES160
6.4.1.1Leading players provide pre-assembled filtration assemblies160
TABLE 114GLOBAL FILTRATION ASSEMBLIES MARKET, BY REGION, 2021–2028 (USD MILLION)161
TABLE 115NORTH AMERICA: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)161
TABLE 116EUROPE: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)162
TABLE 117ASIA PACIFIC: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)162
TABLE 118LATIN AMERICA: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)163
6.4.2FILTER HOLDERS163
6.4.2.1Filter holders provide structural support to membrane filters163
TABLE 119GLOBAL FILTER HOLDERS MARKET, BY REGION, 2021–2028 (USD MILLION)163
TABLE 120NORTH AMERICA: FILTER HOLDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)164
TABLE 121EUROPE: FILTER HOLDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)164
TABLE 122ASIA PACIFIC: FILTER HOLDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)164
TABLE 123LATIN AMERICA: FILTER HOLDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)165
6.4.3FILTRATION ACCESSORIES165
6.4.3.1Increasing adoption of pharmaceutical filtration products to support growth165
TABLE 124GLOBAL PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION)165
TABLE 125NORTH AMERICA: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)166
TABLE 126EUROPE: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)166
TABLE 127ASIA PACIFIC: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)167
TABLE 128LATIN AMERICA: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)167
7PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE168
7.1INTRODUCTION169
TABLE 129GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)169
7.2MICROFILTRATION169
7.2.1INCREASED ADOPTION OF MICROFILTRATION TO PROPEL MARKET GROWTH169
TABLE 130GLOBAL MICROFILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION)170
TABLE 131NORTH AMERICA: MICROFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)170
TABLE 132EUROPE: MICROFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)170
TABLE 133ASIA PACIFIC: MICROFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)171
TABLE 134LATIN AMERICA: MICROFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)171
7.3ULTRAFILTRATION171
7.3.1ADOPTION OF FINE FILTRATION TECHNIQUES TO DRIVE GROWTH171
TABLE 135GLOBAL ULTRAFILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION)172
TABLE 136NORTH AMERICA: ULTRAFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)172
TABLE 137EUROPE: ULTRAFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)173
TABLE 138ASIA PACIFIC: ULTRAFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)173
TABLE 139LATIN AMERICA: ULTRAFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)173
 
7.4NANOFILTRATION174
7.4.1HIGH ENERGY CONSUMPTION TO HINDER MARKET GROWTH174
TABLE 140GLOBAL NANOFILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION)174
TABLE 141NORTH AMERICA: NANOFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)175
TABLE 142EUROPE: NANOFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)175
TABLE 143ASIA PACIFIC: NANOFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)175
TABLE 144LATIN AMERICA: NANOFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)176
7.5OTHER TECHNIQUES176
TABLE 145GLOBAL OTHER TECHNIQUES MARKET, BY REGION, 2021–2028 (USD MILLION)176
TABLE 146NORTH AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)177
TABLE 147EUROPE: OTHER TECHNIQUES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)177
TABLE 148ASIA PACIFIC: OTHER TECHNIQUES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)178
TABLE 149LATIN AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)178
8PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION179
8.1INTRODUCTION180
TABLE 150GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)180
8.2FINAL PRODUCT PROCESSING180
TABLE 151GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY REGION, 2021–2028 (USD MILLION)181
TABLE 152NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION)181
TABLE 153EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION)182
TABLE 154ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION)182
TABLE 155LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION)183
TABLE 156GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION)183
8.2.1ACTIVE PHARMACEUTICAL INGREDIENT (API) FILTRATION183
8.2.1.1Continuous requirement for API filtration to drive market growth183
TABLE 157GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION)184
TABLE 158NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)184
TABLE 159EUROPE: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)185
TABLE 160ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)185
TABLE 161LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)186
8.2.2PROTEIN PURIFICATION186
8.2.2.1Recent advancements in protein therapeutic drugs to propel growth186
TABLE 162GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY REGION, 2021–2028 (USD MILLION)187
TABLE 163NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION)187
TABLE 164EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION)188
TABLE 165ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION)188
TABLE 166LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION)189
8.2.3VACCINE AND ANTIBODY PROCESSING189
8.2.3.1Development of vaccines for COVID-19 and other viral diseases to drive growth189
TABLE 167GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY REGION, 2021–2028 (USD MILLION)189
TABLE 168NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION)190
TABLE 169EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION)190
TABLE 170ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION)191
TABLE 171LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION)191
8.2.4FORMULATION AND FILLING SOLUTIONS191
8.2.4.1Demand for aseptic filling and bioburden reduction to propel growth191
TABLE 172GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY REGION, 2021–2028 (USD MILLION)192
TABLE 173NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)192
TABLE 174EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)193
TABLE 175ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)193
TABLE 176LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)194
8.2.5VIRAL CLEARANCE194
8.2.5.1Growing development of therapeutic monoclonal antibodies to drive market194
TABLE 177GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY REGION, 2021–2028 (USD MILLION)195
TABLE 178NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2021–2028 (USD MILLION)195
TABLE 179EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2021–2028 (USD MILLION)196
TABLE 180ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2021–2028 (USD MILLION)196
TABLE 181LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2021–2028 (USD MILLION)197
8.3RAW MATERIAL FILTRATION197
TABLE 182GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY REGION, 2021–2028 (USD MILLION)197
TABLE 183NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION)198
TABLE 184EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION)198
TABLE 185ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION)199
TABLE 186LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION)199
TABLE 187GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION)199
8.3.1MEDIA BUFFER FILTRATION200
8.3.1.1Growth in manufacturing of biopharmaceuticals to drive market200
TABLE 188GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY REGION, 2021–2028 (USD MILLION)200
TABLE 189NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION)201
TABLE 190EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION)201
TABLE 191ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION)202
TABLE 192LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION)202
8.3.2PREFILTRATION203
8.3.2.1Membrane fouling issues to drive growth203
TABLE 193GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY REGION, 2021–2028 (USD MILLION)203
TABLE 194NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2021–2028 (USD MILLION)203
TABLE 195EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2021–2028 (USD MILLION)204
TABLE 196ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2021–2028 (USD MILLION)204
TABLE 197LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2021–2028 (USD MILLION)205
8.3.3BIOBURDEN TESTING205
8.3.3.1Strict quality control of biopharmaceuticals to drive growth205
TABLE 198GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY REGION, 2021–2028 (USD MILLION)205
TABLE 199NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2021–2028 (USD MILLION)206
TABLE 200EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2021–2028 (USD MILLION)206
TABLE 201ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2021–2028 (USD MILLION)207
TABLE 202LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2021–2028 (USD MILLION)207
8.4CELL SEPARATION208
8.4.1GROWTH IN PERSONALIZED MEDICINE TO PROPEL MARKET208
TABLE 203GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY REGION, 2021–2028 (USD MILLION)208
TABLE 204NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2021–2028 (USD MILLION)208
TABLE 205EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2021–2028 (USD MILLION)209
TABLE 206ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2021–2028 (USD MILLION)209
TABLE 207LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2021–2028 (USD MILLION)210
8.5WATER PURIFICATION210
8.5.1GROWTH IN GERIATRIC POPULATION TO DRIVE MARKET210
TABLE 208GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY REGION, 2021–2028 (USD MILLION)210
TABLE 209NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION)211
TABLE 210EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION)211
TABLE 211ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION)212
TABLE 212LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION)212
8.6AIR PURIFICATION212
8.6.1INCREASING ADOPTION OF GMP PRACTICES TO DRIVE GROWTH212
TABLE 213GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY REGION, 2021–2028 (USD MILLION)213
TABLE 214NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION)213
TABLE 215EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION)214
TABLE 216ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION)214
TABLE 217LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION)215
 
9PHARMACEUTICAL FILTRATION MARKET, BY TYPE216
9.1INTRODUCTION217
TABLE 218GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION)217
9.2STERILE FILTRATION217
9.2.1ADVANTAGES OF STERILE FILTERS OVER NON-STERILE FILTERS TO DRIVE GROWTH217
TABLE 219GLOBAL STERILE FILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION)218
TABLE 220NORTH AMERICA: STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)218
TABLE 221EUROPE: STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)218
TABLE 222ASIA PACIFIC: STERILE FI